European Archives - Page 367 of 1541 - European Medical Journal

Anti-IL-33 Antibody Shows Promise in High-Risk Patients with COPD

Tozorakimab shows potential benefit in patients with COPD with frequent exacerbations, despite primary endpoint not being met in overall population.

Does Metformin Improve Cognitive Impairment in Schizophrenia?

Learn how metformin may enhance cognitive function in schizophrenia by regulating energy metabolism and brain connectivity.

ICML 2025: Regional and Socioeconomic Disparities in CNS Lymphoma Outcomes

A large-scale national study of primary central nervous system lymphoma (PCNSL) in England has revealed stark differences in incidence and survival based on geography, age, and deprivation…

Does Magnesium Aid Glycaemic Control in Type 2 Diabetes?

Understand how magnesium supplementation modestly improves fasting glucose in Type 2 diabetes.

Real-Time Pollen Forecasting App Eases Allergy Symptoms

A recent landmark study is the first randomised, controlled trial to show clinical benefits of an allergy app for SAR sufferers.

Closing Gaps in HAE Management: Understanding What Control Means for Your HAE Patients

This symposium held during the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 in Glasgow, UK, explores evolving…

Machine Learning Improves Liver Transplant Prediction Accuracy

While other machine learning models like MoRAL-AI and TRAIN-AI have also shown promise, TRIUMPH distinguishes itself through its robust generalisability.

ICML 2025: Bridging Radiotherapy May Reduce CAR-T-Related Toxicity

Bridging radiotherapy (BRT) before CAR-T cell therapy may help reduce severe treatment-related toxicities in patients with B-cell lymphoma…

Malaria Prevention in Pregnancy Threatened by Rising Drug Resistance

A major global study confirms that malaria resistance diminishes IPTp-SP’s antimalarial benefits but not its impact on low birthweight, prompting urgent calls for new preventive strategies.

Study Links IBS to Depression and Sexual Dysfunction

New research shows IBS patients suffer higher depression and worse sexual health compared to healthy individuals, highlighting the condition’s broad impact on wellbeing.